156 related articles for article (PubMed ID: 20623629)
1. Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells.
Zhang H; Fang J; Yao D; Wu Y; Ip C; Dong Y
Prostate; 2010 Sep; 70(12):1265-73. PubMed ID: 20623629
[TBL] [Abstract][Full Text] [Related]
2. A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells.
Liu P; Li S; Gan L; Kao TP; Huang H
Cancer Res; 2008 Dec; 68(24):10290-9. PubMed ID: 19074897
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.
Gan L; Chen S; Wang Y; Watahiki A; Bohrer L; Sun Z; Wang Y; Huang H
Cancer Res; 2009 Nov; 69(21):8386-94. PubMed ID: 19826044
[TBL] [Abstract][Full Text] [Related]
4. Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells.
Zhao H; Whitfield ML; Xu T; Botstein D; Brooks JD
Mol Biol Cell; 2004 Feb; 15(2):506-19. PubMed ID: 14617803
[TBL] [Abstract][Full Text] [Related]
5. FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.
Bohrer LR; Liu P; Zhong J; Pan Y; Angstman J; Brand LJ; Dehm SM; Huang H
Prostate; 2013 Jul; 73(10):1017-27. PubMed ID: 23389878
[TBL] [Abstract][Full Text] [Related]
6. Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid.
Zhang H; Wu Y; Malewicz B; Lu J; Li S; Marshall J; Ip C; Dong Y
Cancer; 2006 Dec; 107(12):2942-8. PubMed ID: 17120196
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers.
Dong Y; Zhang H; Gao AC; Marshall JR; Ip C
Mol Cancer Ther; 2005 Jul; 4(7):1047-55. PubMed ID: 16020662
[TBL] [Abstract][Full Text] [Related]
8. MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells.
Lee SH; Kang YJ; Sung B; Kim DH; Lim HS; Kim HR; Kim SJ; Yoon JH; Moon HR; Chung HY; Kim ND
Int J Oncol; 2014 Mar; 44(3):905-11. PubMed ID: 24424889
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
Fan W; Yanase T; Morinaga H; Okabe T; Nomura M; Daitoku H; Fukamizu A; Kato S; Takayanagi R; Nawata H
J Biol Chem; 2007 Mar; 282(10):7329-38. PubMed ID: 17202144
[TBL] [Abstract][Full Text] [Related]
10. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.
Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H
Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104
[TBL] [Abstract][Full Text] [Related]
11. Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.
Liu S; Qi Y; Ge Y; Duplessis T; Rowan BG; Ip C; Cheng H; Rennie PS; Horikawa I; Lustig AJ; Yu Q; Zhang H; Dong Y
Mol Cancer Ther; 2010 Jul; 9(7):2016-25. PubMed ID: 20571066
[TBL] [Abstract][Full Text] [Related]
12. Long‑term exposure to leptin enhances the growth of prostate cancer cells.
Noda T; Kikugawa T; Tanji N; Miura N; Asai S; Higashiyama S; Yokoyama M
Int J Oncol; 2015 Apr; 46(4):1535-42. PubMed ID: 25625287
[TBL] [Abstract][Full Text] [Related]
13. The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1.
Fendler A; Jung M; Stephan C; Erbersdobler A; Jung K; Yousef GM
PLoS One; 2013; 8(11):e80807. PubMed ID: 24260486
[TBL] [Abstract][Full Text] [Related]
14. Camptothecin induces apoptosis of human retinoblastoma cells via activation of FOXO1.
Han S; Wei W
Curr Eye Res; 2011 Jan; 36(1):71-7. PubMed ID: 21174601
[TBL] [Abstract][Full Text] [Related]
15. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
16. FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment.
Ma Q; Fu W; Li P; Nicosia SV; Jenster G; Zhang X; Bai W
Mol Endocrinol; 2009 Feb; 23(2):213-25. PubMed ID: 19074551
[TBL] [Abstract][Full Text] [Related]
17. Modification of androgen receptor function by IGF-1 signaling implications in the mechanism of refractory prostate carcinoma.
Yanase T; Fan W
Vitam Horm; 2009; 80():649-66. PubMed ID: 19251054
[TBL] [Abstract][Full Text] [Related]
18. Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition.
Tarrado-Castellarnau M; Cortés R; Zanuy M; Tarragó-Celada J; Polat IH; Hill R; Fan TW; Link W; Cascante M
Pharmacol Res; 2015 Dec; 102():218-34. PubMed ID: 26375988
[TBL] [Abstract][Full Text] [Related]
19. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells.
Han CY; Cho KB; Choi HS; Han HK; Kang KW
Carcinogenesis; 2008 Sep; 29(9):1837-44. PubMed ID: 18390843
[TBL] [Abstract][Full Text] [Related]
20. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
Zhao Z; Li C; Xi H; Gao Y; Xu D
Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]